Hospitalized HIV patients benefit from seeing infectious diseases specialists

October 4, 2013, Infectious Diseases Society of America

When patients with HIV are hospitalized for other conditions, such as a heart problem, surgery or complications of diabetes, mistakes are often made involving their complicated anti-retroviral therapy (ART) regimens. But those errors are more than twice as likely to be corrected when patients are seen by an infectious diseases (ID) physician, suggests a Cleveland Clinic study being presented at IDWeek 2013 today.

Most patients with HIV are cared for by physicians with HIV expertise in the community, and when they are hospitalized for non-HIV conditions, hospital providers who are unfamiliar with the complexities of HIV therapy may make errors that have an impact on their treatment, from prescribing medications that negatively interact with their ART regimens to providing the wrong dose of medication. The study found those errors can be reduced by employing a variety of interventions, including education, modification of the electronic drug file to help guide the accurate prescribing of medications, and daily medication profile review by a pharmacist specializing in HIV.

Additionally, researchers found involving an physician is key in improving hospital care: Errors were corrected in 68 percent of patients who saw an ID specialist vs. 32 percent of those who did not.

"Most HIV care has shifted from inpatient to outpatient, so hospital providers aren't as familiar with complicated ART regimens – and as a result, are common," said Elizabeth A. Neuner, PharmD, an ID clinical pharmacist at Cleveland Clinic and lead author of the study. "By enacting a multidisciplinary plan including pharmacists and physicians to prevent errors from happening or correcting them if they did, we were able to significantly reduce errors in ART medications."

In the two-part study, researchers looked at 162 patients with HIV who were treated in the hospital before the interventions were put in place, and 110 who were treated after changes were made. Errors – meaning guideline recommendations weren't followed – were made 50 percent of the time before interventions were put in place and 34 percent of time time after. When errors were made, they were resolved 36 percent in the pre-interventions group and 74 percent of the time in the interventions group. Errors were corrected much more quickly in the intervention group: an average of 23 hours, vs. 180 hours in the pre-intervention group.

Corrections varied, for example: prescribing accurate ART medication and dosage; adjusting the regimen because a new medication (such as for heart problems or diabetes) was interacting with one of the ART medications; and revising the therapy due to address a new problem, such as kidney injury. In some cases, physicians opted not to correct the error because the patient was doing well on the therapy and the benefits outweighed the risks.

ART regimens often involve a combination of three or more medications that are taken several times a day.

ID specialists identified medication errors and resolved them such as by changing the dose or frequency of medication, or adding a medication that was missing, said Dr. Neuner.

Explore further: Studies target high rates of HIV medication errors among hospitalized patients

Related Stories

Studies target high rates of HIV medication errors among hospitalized patients

October 19, 2012
Research presented at IDWeek 2012 concludes that despite advances in electronic medical records, mistakes are still commonly made in the prescription of antiretroviral medications for hospitalized HIV-positive patients. At ...

Med errors common among pediatric cancer outpatients

April 29, 2013
(HealthDay)—Among pediatric cancer patients who receive medications at home, errors are common, with a rate of 3.6 errors with injury per 100 patients, according to a study published online April 29 in Pediatrics.

Early intervention by infectious diseases specialists saves lives, reduces costs

September 27, 2013
In a first-of-its-kind study to evaluate the impact of a medical specialty on patient outcomes, researchers found that hospitalized patients with severe infections such as meningitis and Clostridium difficile (C. diff.) are ...

AHRQ offers strategies to prevent adverse drug events

June 21, 2013
(HealthDay)—Strategies to prevent adverse drug events (ADEs) have been recommended and published in a report by the Agency for Healthcare Research and Quality (AHRQ).

Commercial electronic prescribing systems can reduce medication errors in hospital patients

January 31, 2012
A study published in this week's PLoS Medicine shows that commercial electronic prescribing systems (commonly known as e-prescribing, in which prescribers use a computer to order medications for their patients through a system ...

Pharmacist intervention does not prevent medication errors

July 3, 2012
(HealthDay) -- A pharmacist-delivered intervention does not significantly improve the rate of clinically important medication errors following discharge among hospitalized heart patients, according to a study published in ...

Recommended for you

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.